Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

Anne Hansen Ree, Svein Dueland, Sigurd Folkvord, Knut Håkon Hole, Therese Seierstad, Marianne Johansen, Torveig Weum Abrahamsen, Kjersti Flatmark

The Lancet Oncology · 2010 · 124 citations · 7 references

Concepts

References

7